Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Primary Peritoneal Cancer
Related studies linked through entity extraction aliases.
A Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
The Safety and Pharmacokinetics of IMP4297 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int
- Status
- COMPLETED
- Phase
- PHASE1
Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors
- Status
- TERMINATED
- Phase
- N/A
Homologous Recombination Inquiry Through Ovarian Malignancy Investigations
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE2
Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study
- Status
- COMPLETED
- Phase
- N/A
Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2